Skip to content
Forensic Analysis · Chemicals · as of Nov 10, 2026

Albemarle Corp (ALB)

A forensic read on Albemarle Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective
Forensic grade
Safe
Financial health
3.2
Distress distance
Clean
Earnings quality
2
Forensic signals
-5.2%
ROE
-4.4%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Albemarle Corp earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 3.2, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-2.2%
FY2025
Return on invested capital. Return on invested capital is -2.2% in the latest fiscal year, against 1.1% in FY2023, having run between -9.9% and 1.1% across FY2023–FY2025 with no direction held. After-tax operating profit was $164M in FY2023 and ($290M) in FY2025, with operating income at 2.6% of revenue in FY2023, -33.0% in FY2024 and -7.1% in FY2025. The capital base behind it went from $14.4B in FY2023 to $13.4B in FY2025 (-7%), while the revenue it carried went from $9.6B to $5.1B. FY2025's operating profit carried a $181M goodwill write-off that alone took about 1.1 points off that year's return, so about 1.1 of the 3.3-point fall across FY2023–FY2025 is that charge landing in the latest year rather than the capital earning less. A non-cash write-down lowers the reported return in the year it lands.
$181M
FY2025
Goodwill impairments. Took $181M of goodwill writedowns across 1 year (FY2025 ($181M)). Writedowns mean past acquisitions underperformed what was paid for them.

Key fundamentals

Latest Revenue$5.14B
Revenue Growth YoY-4.4%
Revenue CAGR (2yr)-26.9%
Net Margin-9.9%
Free Cash Flow$692.5M
Return on Equity-5.2%
Debt / Equity0.33x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Albemarle Corp's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 10, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.